ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

Anlotinib Induces a T Cell-Inflamed Tumor Microenvironment by Facilitating Vessel Normalization and Enhances the Efficacy of PD-1 Checkpoint Blockade in Neuroblastoma.

Yudong Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.